ArticleInvestigational new drugs2016

Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.

Bence Kapuvári et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.